These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22876919)

  • 41. Adipokines and coronary vasomotor dysfunction.
    Knudson JD; Dick GM; Tune JD
    Exp Biol Med (Maywood); 2007 Jun; 232(6):727-36. PubMed ID: 17526764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
    Kawashima K; Maeda K; Saigo C; Kito Y; Yoshida K; Takeuchi T
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1)-deacetylase and peroxisome proliferator-activated receptors (PPARs).
    Jin T; Kim OY; Shin MJ; Choi EY; Lee SS; Han YS; Chung JH
    J Agric Food Chem; 2014 Oct; 62(43):10468-74. PubMed ID: 25286082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adiponectin and its role in cardiovascular diseases.
    Bełtowski J; Jamroz-Wiśniewska A; Widomska S
    Cardiovasc Hematol Disord Drug Targets; 2008 Mar; 8(1):7-46. PubMed ID: 18336252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies.
    Murthy NS; Mukherjee S; Ray G; Ray A
    J Postgrad Med; 2009; 55(1):45-54. PubMed ID: 19242081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of adiponectin signaling in metabolic syndrome and cancer.
    Scheid MP; Sweeney G
    Rev Endocr Metab Disord; 2014 Jun; 15(2):157-67. PubMed ID: 24019064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of adiponectin in obesity related gastrointestinal carcinogenesis.
    Nagaraju GP; Aliya S; Alese OB
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):83-93. PubMed ID: 25007742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adiponectin receptors in energy homeostasis and obesity pathogenesis.
    Akingbemi BT
    Prog Mol Biol Transl Sci; 2013; 114():317-42. PubMed ID: 23317789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adiponectin, Leptin and Cardiovascular Disorders.
    Zhao S; Kusminski CM; Scherer PE
    Circ Res; 2021 Jan; 128(1):136-149. PubMed ID: 33411633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
    Powell LA; Crowe P; Kankara C; McPeake J; McCance DR; Young IS; Trimble ER; McGinty A
    Clin Sci (Lond); 2012 Aug; 123(3):135-46. PubMed ID: 22309242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adiponectin and cardiovascular disease: state of the art?
    Szmitko PE; Teoh H; Stewart DJ; Verma S
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adiponectin levels and sleep deprivation in patients with endocrine metabolic disorders.
    Oliveira RF; Daniele TMDC; Façanha CFS; Forti ACE; Bruin PFC; Bruin VMS
    Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1122-1128. PubMed ID: 30569989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
    Kopff B; Jegier A
    Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adiponectin in health and disease.
    Oh DK; Ciaraldi T; Henry RR
    Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adipokines and Their Receptors Are Widely Expressed and Distinctly Regulated by the Metabolic Environment in the Prostate of Male Mice: Direct Role Under Normal and Tumoral Conditions.
    Sarmento-Cabral A; L-López F; Luque RM
    Endocrinology; 2017 Oct; 158(10):3540-3552. PubMed ID: 28938461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome.
    Bueno AC; Sun K; Martins CS; Elias Junior J; Miranda W; Tao C; Foss-Freitas MC; Barbieri MA; Bettiol H; de Castro M; Scherer PE; Antonini SR
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E683-93. PubMed ID: 24432991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease.
    Matsuzawa Y
    Atheroscler Suppl; 2005 May; 6(2):7-14. PubMed ID: 15823491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
    Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.